Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Aarti Drugs Limited (NSE: AARTIDRUGS), ISIN INE767A01016 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
AARTIDRUGS last traded at ₹502.80 (+11.76%), with a 52-week range of ₹318.95 to ₹534.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 54.07%, FIIs 2.26%, DIIs 10.24%, mutual funds 9.97%.
EquiSense Score (ECS): 73/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.